Anixa Biosciences, Inc
Price
FilingsNewest: 10-Q, Quarterly reportSep 9 →Insiders3 insiders bought $90,387 in 3 open-market buys. No sales.→HoldersVanguard 3.8%UBS 1.7%Laird Norton Wetherby Trust 1.7%→Financing →PeersClosest companies: COYA, CTMX, GOVX→
From the filings
Figures
- Net income
- −$10.4Mlast 12 months
- Operating cash flow
- −$7.1Mlast 12 months
- Cash and equivalents
- $1.4Mat the last balance sheet
- Shares outstanding
- 34.6M shareson issue